Global COVID-19 Rapid Test Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global COVID-19 Rapid Test Market Research Report 2024
In addition to the genetic information carried by DNA/RNA, the protein envelope of the virus also carries a lot of information about the structure and pathogenesis of the virus, which can also determine whether the patient is infected with the virus and has immunity to the virus.Nucleic acid detection relies on primers, and detection of viral proteins mainly relies on antibodies. As long as the antibody with high enough affinity and good enough specificity is found, the tedious steps of extracting viral RNA can be eliminated, and the serum or sputum of patients at the onset of the disease can be directly used for protein immunoassay (ELISA), and the results can be obtained within 3-5 hours.
According to MRA Research’s new survey, global COVID-19 Rapid Test market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole COVID-19 Rapid Test market research.
Key companies engaged in the COVID-19 Rapid Test industry include SureScreen, Confirm Biosciences, Biopanda Reagents, Bosch, Roche, Seegene, CVS Health and Abbott, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of COVID-19 Rapid Test were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole COVID-19 Rapid Test market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global COVID-19 Rapid Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
SureScreen
Confirm Biosciences
Biopanda Reagents
Bosch
Roche
Seegene
CVS Health
Abbott
Segment by Type
COVID-19 Nucleic Acid Detection
COVID-19 Antibody Detection
Hospital
Scientific Research
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The COVID-19 Rapid Test report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRA Research’s new survey, global COVID-19 Rapid Test market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole COVID-19 Rapid Test market research.
Key companies engaged in the COVID-19 Rapid Test industry include SureScreen, Confirm Biosciences, Biopanda Reagents, Bosch, Roche, Seegene, CVS Health and Abbott, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of COVID-19 Rapid Test were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole COVID-19 Rapid Test market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global COVID-19 Rapid Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
SureScreen
Confirm Biosciences
Biopanda Reagents
Bosch
Roche
Seegene
CVS Health
Abbott
Segment by Type
COVID-19 Nucleic Acid Detection
COVID-19 Antibody Detection
Segment by Application
Hospital
Scientific Research
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The COVID-19 Rapid Test report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source